Technology & Pipeline

We are currently developing our antibiotic product candidate, OG716 as well as other homolog antibiotic product candidates, and have other product candidates, including SMaRT Replacement Therapy positioned for outlicensing or partnering.

Technology Candidate Indication Development Stage
Preclinical Phase 1 Phase 2 Phase 3 Market
Lantibiotics OG716 C.difficile
Preclinical Phase in progress
Phase 1 Phase not started
Phase 2 Phase not started
Phase 3 Phase not started
Market Phase not started


Lantibiotics are a class of antibiotics with a novel mechanism of action active against several multi-drug resistant organisms.

View Lantibiotics ยป